VASCU-PICC® MD17012600 (UDI 00884908180183)Recalls & reported problems
Medical Components, Inc. · 2.6F X 50CM DUAL LUMEN VASCU-PICC® CATHETER ONLY · Class 2 · Implant
All models of VASCU-PICC (22)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 6
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 6 adverse event reports that list this exact device (DI 00884908180183), received between Sep 9, 2025 and May 26, 2026 — classified as 6 malfunctions.
The most frequently reported specific device problem is “Leak/Splash” (6 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Leak/Splash6
- Flushing Problem1
Patient problems
- No Clinical Signs, Symptoms or Conditions5
- Pain1
Recent adverse event reports
The 6 most recent of 6 reports, in the reporter's own words as published by the FDA.
MalfunctionMay 26, 2026Leak/Splash
THE NURSE WAS PLACING A PICC [PERIPHERALLY INSERTED CENTRAL CATHETER] LINE IN PATIENT AS ORDERED. THE PATIENT WAS PREPPED AND A 3 FRENCH 5CM INTRODUCER/DILATOR WAS INSERTED WITHOUT ISSUE. A 2.6 FRENCH DOUBLE LUMEN PICC WAS THEN OPENED AND ADVANCED THROUGH THE INTRODUCER WITHOUT RESISTANCE. WHILE FLUSHING THE PICC TO CHECK FOR PATENCY, THE RED LUMEN WAS NOTED TO BE LEAKING AT THE INSERTION SITE. THE WHITE LUMEN REMAINED INTACT. A DEFECT OF THE PICC LINE WAS IDENTIFIED AND THE LINE WAS REMOVED AND REPLACED WITH ANOTHER 2.6 FRENCH DOUBLE LUMEN PICC OF THE SAME LOT NUMBER. NO LEAKING WAS NOTED IN EITHER LUMEN OF THE SECOND PICC LINE PLACED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 25278941 ↗MalfunctionApr 27, 2026Leak/Splash
FLUSHING BOTH SIDES RESULTED IN A LUMEN LEAK.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24997819 ↗MalfunctionMar 4, 2026Leak/Splash
INSERTING PICC AND NOTICED FLUID COMING OUT OF THE CATHETER AROUND THE 3 CM MARK. IT APPEARS THERE IS A SMALL HOLE IN THE CATHETER. PICC WAS REMOVED AT THE TIME OF INSERTION.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24508157 ↗MalfunctionDec 1, 2025Flushing Problem; Leak/Splash; Flushing Problem; Leak/Splash
RN'S HAVE EXPERIENCED DIFFICULTY IN THE PAST 24 HOURS WITH FLUSHING AND WITHDRAWING BLOOD FROM THE RED LUMEN OF PATIENT'S 2.6F PICC CATHETER. PATIENT NOW COMPLAINING OF PAIN AT INSERTION SITE WHEN ATTEMPTS AT FLUSHING THE RED LUMEN OCCUR. BEDSIDE RN NOTIFIED ATTENDING MD AND RED LUMEN TO NO LONGER BE USED AT THIS TIME. IVT CONSULTED. IR CONSULT PLACE AND PLAN FOR PATIENT TO GET LINE RE-WIRED/REPLACED.
Patient problems: Pain
MAUDE report 23683928 ↗MalfunctionDec 1, 2025Leak/Splash; Leak/Splash
ISSUE IDENTIFIED WITH WHITE LUMEN OF LUE(LEFT UPPER EXTREMITY) 2.6FR PICC WAS FLUSHED WITH 10MLS OF NSS AS PER POLICY. RN CLAMPED THE LINE AND PAGED IV TEAM. DURING THE DAY RUE(RIGHT UPPER EXTREMITY) US OBTAINED THAT WAS UNREMARKABLE. CARDIAC INTENSIVE CARE UNIT AND PERIPHERAL NERVOUS SYSTEM CHANGED THE DRESSING TO ENSURE THERE WAS NO MECHANICAL OBSTRUCTION. RED LUMEN FLUSHED AT THIS TIME AND FLUSHED AND WITHDREW BLOOD WITHOUT ISSUE. WHEN PATIENT'S WHITE LUMEN WAS FLUSHED THE NSS IMMEDIATELY FILLED THE DRESSING WINDOW AND BIOPATCH. CARDIOLOGY APP CALLED TO BEDSIDE AND LINE WAS REMOVED AT THIS TIME. A VISIBLE TEAR IN THE CATHETER WAS PRESENT AFTER REMOVAL AND FOUND TO BE 1.5CM PAST THE HUB OF THE CATHETER.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23681188 ↗MalfunctionSep 9, 2025Leak/Splash; Leak/Splash
WHEN PERFORMING AN OVER THE WIRE ON THE PATIENT PHYSICIAN WAS ABLE TO THREAD THE WIRE INTO THE LINE BUT WHEN IT WAS TIME TO PULL THE LINE OUT, A POP WAS FELT AND THE LINE COULD NOT BE PULLED UNLESS BOTH THE GUIDE WIRE AND THE LINE WERE PULLED. THE RESULT WAS LOSS OF ACCESS AND PARENTS REFUSED TO HAVE A NEW PICC PLACED IN ANOTHER LIMB AT THIS TIME. WHEN THE MOTHER WAS, SHE DID STATE THAT WHEN THEY HAD BEEN DISCHARGED AND SHE FLUSHED THE LINE AND FELT A POP. PRIOR TO OVER THE WIRING THE LINE IT WAS NOTICED THAT THE LINE WAS LEAKING AND MOST LIKELY HAD A RUPTURE IN THE LINE PRIOR TO THE OVER THE WIRE WAS ATTEMPTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23003256 ↗
Other Catheter, intravascular, therapeutic, long-term greater than 30 days devices
- Groshong NXT ClearVue Catheter 7617405Bard Access Systems, Inc. · Catheter,intravascular,therapeutic,long-term greater than 30 days2 deaths1,708 reports
- Groshong NXT ClearVue Catheter 7655405Bard Access Systems, Inc. · Catheter,intravascular,therapeutic,long-term greater than 30 days2 deaths1,536 reports
- PowerPICC Catheter 3174118Bard Access Systems, Inc. · Catheter,intravascular,therapeutic,long-term greater than 30 days1 recall402 reports
- L-Cath™ S/L PICC S/L 26GA (1.9F) x 30cmArgon Medical Devices, Inc. · Catheter,Intravascular,Therapeutic,Long-Term Greater Than 30 Days2 recalls245 reports
- PowerPICC SOLO2 Catheter 1194108DBard Access Systems, Inc. · Catheter,intravascular,therapeutic,long-term greater than 30 days2 recalls216 reports
- Broviac 0600520Bard Access Systems, Inc. · Catheter,intravascular,therapeutic,long-term greater than 30 days1 recall265 reports
- Groshong® Catheter 7717405Bard Access Systems, Inc. · Catheter,intravascular,therapeutic,long-term greater than 30 days279 reports
- PowerPICC Catheter 3275118Bard Access Systems, Inc. · Catheter,intravascular,therapeutic,long-term greater than 30 days272 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page